CAS 1009583-20-3

Fórmula: C21H27NO3

InChI: InChI=1S/C21H27NO3/c23-18-11-22(12-18)19(24)10-21(15-4-2-1-3-5-15)16-6-13-7-17(21)9-14(8-16)20(13)25/h1-5,13-14,16-18,20,23,25H,6-12H2

Chave InChI: OAAZMUGLOXGVNH-UHFFFAOYSA-N

SMILES: C1C2CC3CC(C2O)CC1C3(CC(=O)N4CC(C4)O)C5=CC=CC=C5

BMS-816336

CAS: 1009583-20-3

BMS-816336

Fórmula: C₂₁H₂₇NO₃

Pureza: 99.86%

Peso molecular: 341.44

Ref: 54-OR1130931

BMS-816336

CAS: 1009583-20-3

Fórmula: C₂₁H₂₇NO₃

Pureza: 99.86%

Peso molecular: 341.444

Ref: IN-DA01V1RD

BMS-816336

CAS: 1009583-20-3

BMS-816336 is a purine derivative that inhibits protein synthesis. It has been shown to have a significant effect on lowering blood pressure in women with high blood pressure and/or body mass indices (BMI) over 30 kg/m2. BMS-816336 has also been shown to increase insulin sensitivity in mice by reducing the levels of fatty acids and volatile fatty acids, which are metabolites that can cause insulin resistance. The molecular modeling of this drug showed that it binds to the active site of eEF1A, an enzyme involved in the process of protein synthesis.

Fórmula: C₂₁H₂₇NO₃

Pureza: Min. 95%

Peso molecular: 341.4 g/mol

Ref: 3D-BA179856